This International Women’s Day, let us appreciate the female
role models in our #WomenInSTEM series, who are making a
big difference in the fields of research and life sciences for a
better world.
Findings of NPM Phase I, provide opportunities for deeper understanding of
genomic diversity in Asian populations, for more accurate diagnosis and treatment.
PRECISE funded BREATHE programme to transform breast cancer
screening from age-based to risk-based approach
Singapore has valuable research and real-world data managed by different research institutions and public sector agencies. Such data range from genomic to behavioural to socio-economic data. These data, when brought together securely and used in an anonymised manner, have immense potential to enable understanding in health conditions, develop new medical treatments, plan health programmes, and improve public health policy.
SG10K_Health is the headline project of the Singapore National Precision Medicine programme (NPM Phase I). Comprising 10,000 whole-genome sequences from healthy Chinese, Indian, and Malay consented volunteers. SG10K_Health involved a research collaboration across multiple institutions in Singapore, enabling the country to develop the necessary infrastructure and deep capabilities to process, store, and analyse genetic data at the population scale in a safe, secure, and rapid manner. Learn more >
Instead of treating all patients the same way, precision medicine takes individual variations in genetics, environmental and lifestyle factors into account, allowing doctors to more accurately predict which treatment and prevention strategies will work in different groups of people. Enabled by tools to analyse data on a large scale and with DNA sequencing becoming more affordable, precision medicine can improve healthcare by giving doctors a more detailed understanding of each patient.